(Q48417985)

11 February 2018

title

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. (English)

1 reference

11 February 2018

0 references

0 references

7

1 reference

11 February 2018

Axel Petzold

object named as

A Petzold

1

0 references

Alison J. E. Green

4

object named as

A J E Green

1 reference

11 February 2018

author name string

R Jenkins

2

1 reference

11 February 2018

H C Watt

3

1 reference

11 February 2018

E J Thompson

5

1 reference

11 February 2018

G Keir

6

1 reference

11 February 2018

M N Rossor

8

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 January 2003

1 reference

11 February 2018

published in

Neuroscience Letters

1 reference

11 February 2018

volume

336

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

167-170

1 reference

11 February 2018

Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Rates of global and regional cerebral atrophy in AD and frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Visualisation and quantification of rates of atrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901257-0

7 January 2021

10.1016/S0304-3940(02)01257-0

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018